Prescription Drugs
-
5 Must-Knows Before Thursday’s Stock Market Open
Stellantis shares plunged over 25% following a projected $26 billion business overhaul impact. Meanwhile, stock futures rebounded. Market volatility persists, with AI spending concerns impacting equities and crypto. Amazon’s significant capital expenditure plans, especially for data centers, also drew investor caution. Amidst these, the Trump administration launched TrumpRx to lower drug prices, and Bob’s Discount Furniture debuted on NYSE. However, Peloton and Estée Lauder saw significant drops. The AI sector also saw competition heat up with OpenAI and Anthropic exchanging jabs during Super Bowl ad season.
